Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTA 402 in Hepatic Dysfunction
NCT00550849Phase 2Terminated
- Sponsor
- Biogen
- Start
- Apr 2007
- Primary completion
- Nov 2007
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bardoxolone methyl in chronic liver disease (CLD), sponsored by Biogen. Started Apr 2007; status: terminated.
02
Drugs
bardoxolone methyl
03
Conditions
chronic liver disease (CLD)
Beyond the preview
Go deeper on NCT00550849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550849.